Behavioral testing in rodent models of orofacial neuropathic and inflammatory pain

Brain and Behavior

Volumn 2, Issue 5, 2012, Pages 678-697

  Krzyzanowska, Agnieszka ^a   Avendaño, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Facial pain; Pain models; TMD; Trigeminal neuralgia

Indexed keywords

ACETYLSALICYLIC ACID; ALLYL ISOTHIOCYANATE; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; CAPSAICIN; CARBAMAZEPINE; CARRAGEENAN; CORTICOSTEROID; FORMALDEHYDE; FREUND ADJUVANT; GABAPENTIN; INDOMETACIN; INTERLEUKIN 1BETA; LAMOTRIGINE; LIPOPOLYSACCHARIDE; LYSOPHOSPHATIDIC ACID; MENTHOL; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXCARBAZEPINE; PARACETAMOL; PHENYTOIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VANILLOID RECEPTOR 1; ZYMOSAN;

ALLODYNIA; ARTICLE; BEHAVIOR; COORDINATION DISORDER; DEMYELINATION; DISEASE MODEL; DROWSINESS; DRUG EFFICACY; DRUG MEGADOSE; EVOKED RESPONSE; FACE PAIN; HINDLIMB; HUMAN; HYPERALGESIA; INFLAMMATORY PAIN; INFRAORBITAL NERVE; INSTRUMENTAL CONDITIONING; LOW DRUG DOSE; MIGRAINE; MOTOR DYSFUNCTION; NERVE COMPRESSION; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; OROFACIAL PAIN; PAIN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RODENT; SINGLE DRUG DOSE; TAIL; TEMPOROMANDIBULAR JOINT DISORDER; TRIGEMINUS GANGLION; TRIGEMINUS NEURALGIA;

EID: 84887022105     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.85     Document Type: Article

References (150)

1. Ahn, D. K., C. Y. Jung, H. J. Lee, H. S. Choi, J. S. Ju, and Y. C. Bae 2004. Peripheral glutamate receptors participate in interleukin-1[beta]-induced mechanical allodynia in the orofacial area of rats. Neurosci. Lett. 357:203-206.
2. Ahn, D. K., S. Y. Lee, S. R. Han, J. S. Ju, G. Y. Yang, M. K. Lee, et al. 2009a. Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats. Pain 146:114-120.
3. Ahn, D. K., E. J. Lim, B. C. Kim, G. Y. Yang, M. K. Lee, J. S. Ju, et al. 2009b. Compression of the trigeminal ganglion produces prolonged nociceptive behavior in rats. Eur. J. Pain 13:568-575.
4. Aita, M., M. R. Byers, C. Chavkin, and M. Xu 2010. Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice. Mol. Pain 6:8.
5. Alper, B. S., and P. R. Lewis 2002. Treatment of postherpetic neuralgia: a systematic review of the literature. J. Fam. Pract. 51:121-128.
6. Alvarez, P., G. Saavedra, A. Hernandez, C. Paeile, and T. Pelissier 2003. Synergistic antinociceptive effects of ketamine and morphine in the orofacial capsaicin test in the rat. Anesthesiology 99:969-975.
7. Alvarez, P., A. Brun, A. Labertrandie, J. Lopez, A. Correa, L. Constandil, et al. 2011. Antihyperalgesic effects of clomipramine and tramadol in a model of posttraumatic trigeminal neuropathic pain in mice. J. Orofac. Pain 25:354-363.
8. Ambalavanar, R., D. Dessem, A. Moutanni, C. Yallampalli, U. Yallampalli, P. Gangula, et al. 2006. Muscle inflammation induces a rapid increase in calcitonin gene-related peptide (CGRP) mRNA that temporally relates to CGRP immunoreactivity and nociceptive behavior. Neuroscience 143:875-884.
9. Ambalavanar, R., C. Yallampalli, U. Yallampalli, and D. Dessem 2007. Injection of adjuvant but not acidic saline into craniofacial muscle evokes nociceptive behaviors and neuropeptide expression. Neuroscience 149:650-659.
10. Bakke, M., J. W. Hu, and B. J. Sessle 1998. Morphine application to peripheral tissues modulates nociceptive jaw reflex. NeuroReport 9:3315-3319.
11. Le Bars, D., M. Gozariu, and S. W. Cadden 2001. Animal models of nociception. Pharmacol. Rev. 53:597-652.
12. Benoliel, R., J. Epstein, E. Eliav, R. Jurevic, and S. Elad 2007. Orofacial pain in cancer: part I - mechanisms. J. Dent. Res. 86:491-505.
13. Benoliel, R., N. Birman, E. Eliav, and Y. Sharav 2008. The International Classification of Headache Disorders: accurate diagnosis of orofacial pain? Cephalalgia 28:752-762.
14. Benoliel, R., P. Svensson, G. M. Heir, D. Sirois, J. Zakrzewska, J. Oke-Nwosu, et al. 2011. Persistent orofacial muscle pain. Oral Dis. 17(Suppl 1):23-41.
15. Bereiter, D. A., and A. P. Benetti 1996. Excitatory amino release within spinal trigeminal nucleus after mustard oil injection into the temporomandibular joint region of the rat. Pain 67:451-459.
16. Bereiter, D. A., H. Hirata, and J. W. Hu 2000. Trigeminal subnucleus caudalis: beyond homologies with the spinal dorsal horn. Pain 88:221-224.
17. Bonjardim, L. R., A. P. da Silva, G. H. Gameiro, C. H. Tambeli, Ferraz de Arruda, and M. C. Veiga 2009. Nociceptive behavior induced by mustard oil injection into the temporomandibular joint is blocked by a peripheral non-opioid analgesic and a central opioid analgesic. Pharmacol. Biochem. Behav. 91:321-326.
18. Bornhof, M., H. Ihmsen, H. Schwilden, D. C. Yeomans, and A. Tzabazis 2011. The orofacial formalin test in mice revisited-effects of formalin concentration, age, morphine and analysis method. J. Pain 12:633-639.
19. Borsani, E., S. Bernardi, R. Albertini, R. Rezzani, and L. F. Rodella 2009. Alterations of AQP2 expression in trigeminal ganglia in a murine inflammation model. Neurosci. Lett. 449:183-188.
20. Bouloux, G. F. 2011. Use of opioids in long-term management of temporomandibular joint dysfunction. J. Oral Maxillofac. Surg. 69:1885-1891.
21. Cairns, B. E. 2010. Pathophysiology of TMD pain - basic mechanisms and their implications for pharmacotherapy. J. Oral Rehabil. 37:391-410.
22. Cairns, B. E., G. Gambarota, P. Svensson, L. Arendt-Nielsen, and C. B. Berde 2002. Glutamate-induced sensitization of rat masseter muscle fibers. Neuroscience 109:389-399.
23. Cascos-Romero, J., E. Vazquez-Delgado, E. Vazquez-Rodriguez, and C. Gay-Escoda 2009. The use of tricyclic antidepressants in the treatment of temporomandibular joint disorders: systematic review of the literature of the last 20 years. Med. Oral Patol. Oral Cir. Bucal. 14:E3-E7.
24. Castrillon, E. E., B. E. Cairns, M. Ernberg, K. Wang, B. J. Sessle, L. Arendt-Nielsen, et al. 2008. Effect of peripheral NMDA receptor blockade with ketamine on chronic myofascial pain in temporomandibular disorder patients: a randomized, double-blinded, placebo-controlled trial. J. Orofac. Pain 22:122-130.
25. Chichorro, J. G., A. R. Zampronio, G. E. Souza, and G. A. Rae 2006. Orofacial cold hyperalgesia due to infraorbital nerve constriction injury in rats: reversal by endothelin receptor antagonists but not non-steroidal anti-inflammatory drugs. Pain 123:64-74.
26. Chichorro, J. G., A. R. Zampronio, D. A. Cabrini, C. R. Franco, and G. A. Rae 2009. Mechanisms operated by endothelin ETA and ETB receptors in the trigeminal ganglion contribute to orofacial thermal hyperalgesia induced by infraorbital nerve constriction in rats. Neuropeptides 43:133-142.
27. Christensen, D., M. Gautron, G. Guilbaud, and V. Kayser 1999. Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain. Pain 83:433-440.
28. Christensen, D., M. Gautron, G. Guilbaud, and V. Kayser 2001. Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain 93:147-153.
29. Clavelou, P., J. Pajot, R. Dallel, and P. Raboisson 1989. Application of the formalin test to the study of orofacial pain in the rat. Neurosci. Lett. 103:349-353.
30. Cooper, S. A., and P. J. Desjardins 2010. The value of the dental impaction pain model in drug development. Methods Mol. Biol. 617:175-190.
31. Cruccu, G., A. Biasiotta, S. Di Rezze, M. Fiorelli, F. Galeotti, P. Innocenti, et al. 2009. Trigeminal neuralgia and pain related to multiple sclerosis. Pain 143:186-191.
32. Cuellar, J., N. Manering, M. Klukinov, M. Nemenov, and D. Yeomans 2010. Thermal nociceptive properties of trigeminal afferent neurons in rats. Mol. Pain 6:39.
33. Dallel, R., P. Raboisson, P. Clavelou, M. Saade, and A. Woda 1995. Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin. Pain 61:11-16.
34. Deseure, K., W. Koek, F. C. Colpaert, and H. Adriaensen 2002. The 5-HT1A receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain. Eur. J. Pharmacol. 456:51-57.
35. Dessem, D., R. Ambalavanar, M. Evancho, A. Moutanni, C. Yallampalli, and G. Bai 2010. Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X(3) expression in a functionally relevant manner. Pain 149:284-295.
36. Devor, M., R. Amir, and Z. H. Rappaport 2002. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin. J. Pain 18:4-13.
37. Dolan, J. C., D. K. Lam, S. H. Achdjian, and B. L. Schmidt 2010. The dolognawmeter: a novel instrument and assay to quantify nociception in rodent models of orofacial pain. J. Neurosci. Methods 187:207-215.
38. Eisenberg, E., B. P. Vos, and A. M. Strassman 1996. The peripheral antinociceptive effect of morphine in a rat model of facial pain. Neuroscience 72:519-525.
39. Ekberg, E. 1998. Treatment of temporomandibular disorders of arthrogeneous origin. Controlled double-blind studies of a non-steroidal anti-inflammatory drug and a stabilisation appliance. Swed. Dent. J. Suppl. 131:1-57.
40. Eriksson, J., A. Jablonski, A. K. Persson, J. X. Hao, P. F. Kouya, Z. Wiesenfeld-Hallin, et al. 2005. Behavioral changes and trigeminal ganglion sodium channel regulation in an orofacial neuropathic pain model. Pain 119:82-94.
41. Fischer, L., K. E. Torres-Chavez, J. T. Clemente-Napimoga, D. Jorge, F. Arsati, M. C. de Arruda Veiga, et al. 2008. The influence of sex and ovarian hormones on temporomandibular joint nociception in rats. J. Pain 9:630-638.
42. Grabow, T. S., and P. M. Dougherty 2002. Gabapentin produces dose-dependent antinociception in the orofacial formalin test in the rat. Reg. Anesth. Pain Med. 27:277-283.
43. Guo, W., H. Wang, S. Zou, F. Wei, R. Dubner, and K. Ren 2010. Long lasting pain hypersensitivity following ligation of the tendon of the masseter muscle in rats: a model of myogenic orofacial pain. Mol. Pain 6:40.
44. Haas, D. A., O. Nakanishi, R. E. MacMillan, R. C. Jordan, and J. W. Hu 1992. Development of an orofacial model of acute inflammation in the rat. Arch. Oral Biol. 37:417-422.
45. Hanstein, R., J. B. Zhao, R. Basak, D. N. Smith, Y. Y. Zuckerman, M. Hanani, et al. 2010. Focal inflammation causes carbenoxolone-sensitive tactile hypersensitivity in mice. Open Pain J. 3:123-133.
46. Harano, N., K. Ono, K. Hidaka, A. Kai, O. Nakanishi, and K. Inenaga 2010. Differences between orofacial inflammation and cancer pain. J. Dent. Res. 89:615-620.
47. Hargreaves, K. M. 2011. Orofacial pain. Pain 152:S25-S32.
48. Harper, R. P., C. A. Kerins, R. Talwar, R. Spears, B. Hutchins, D. S. Carlson, et al. 2000. Meal pattern analysis in response to temporomandibular joint inflammation in the rat. J. Dent. Res. 79:1704-1711.
49. Hartwig, A. C., S. I. Mathias, A. S. Law, and G. F. Gebhart 2003. Characterization and opioid modulation of inflammatory temporomandibular joint pain in the rat. J. Oral Maxillofac. Surg. 61:1302-1309.
50. Idanpaan-Heikkila, J. J., and G. Guilbaud 1999. Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain 79:281-290.
51. Imamura, Y., H. Kawamoto, and O. Nakanishi 1997. Characterization of heat-hyperalgesia in an experimental trigeminal neuropathy in rats. Exp. Brain Res. 116:97-103.
52. Imbe, H., K. Iwata, Q. Q. Zhou, S. Zou, R. Dubner, and K. Ren 2001. Orofacial deep and cutaneous tissue inflammation and trigeminal neuronal activation. Implications for persistent temporomandibular pain. Cells Tissues Organs 169:238-247.
53. Iwata, K., Y. Tsuboi, A. Shima, T. Harada, K. Ren, K. Kanda, et al. 2004. Central neuronal changes after nerve injury: neuroplastic influences of injury and aging. J. Orofac. Pain 18:293-298.
54. Iwata, K., Y. Imamura, K. Honda, and M. Shinoda 2011. Physiological mechanisms of neuropathic pain: the orofacial region. Int. Rev. Neurobiol. 2011:227-250.
55. Jung, C. Y., H. S. Choi, J. S. Ju, H. S. Park, T. G. Kwon, Y. C. Bae, et al. 2006a. Central metabotropic glutamate receptors differentially participate in interleukin-1beta-induced mechanical allodynia in the orofacial area of conscious rats. J. Pain 7:747-756.
56. Jung, C. Y., S. Y. Lee, H. S. Choi, E. J. Lim, M. K. Lee, G. Y. Yang, et al. 2006b. Participation of peripheral group I and II metabotropic glutamate receptors in the development or maintenance of IL-1beta-induced mechanical allodynia in the orofacial area of conscious rats. Neurosci. Lett. 409:173-178.
57. Kanai, A., A. Suzuki, M. Kobayashi, and S. Hoka 2006. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br. J. Anaesth. 97:559-563.
58. Kanai, A., T. Okamoto, K. Suzuki, Y. Niki, and H. Okamoto 2010. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia. Anesth. Analg. 110:1457-1460.
59. Khan, O. A. 1998. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51:611-614.
60. Khan, A., and K. M. Hargreaves 2010. Animal models of orofacial pain. Methods Mol. Biol. 617:93-104.
61. Kitt, C. A., K. Gruber, M. Davis, C. J. Woolf, and J. D. Levine 2000. Trigeminal neuralgia: opportunities for research and treatment. Pain 85:3-7.
62. Koopman, J. S., J. P. Dieleman, F. J. Huygen, M. de Mos, C. G. Martin, and M. C. Sturkenboom 2009. Incidence of facial pain in the general population. Pain 147:122-127.
63. Koopman, J. S., L. M. de Vries, J. P. Dieleman, F. J. Huygen, B. H. Stricker, and M. C. Sturkenboom 2011. A nationwide study of three invasive treatments for trigeminal neuralgia. Pain 152:507-513.
64. Kruger, L., and R. F. Young 1981. Specialized features of the trigeminal nerve and its central connections. Pp. 274-301 in M. Samii and P. J. Janetta, eds. The cranial nerves. Springer-Verlag, Berlin.
65. Krzyzanowska, A., S. Pittolo, M. Cabrerizo, J. Sanchez-Lopez, S. Krishnasamy, C. Venero, et al. 2011. Assessing nociceptive sensitivity in mouse models of inflammatory and neuropathic trigeminal pain. J. Neurosci. Methods 201:46-54.
66. Lam, D. K., B. J. Sessle, B. E. Cairns, and J. W. Hu 2005. Neural mechanisms of temporomandibular joint and masticatory muscle pain: a possible role for peripheral glutamate receptor mechanisms. Pain Res. Manag. 10:145-152.
67. Langford, D. J., A. L. Bailey, M. L. Chanda, S. E. Clarke, T. E. Drummond, S. Echols, et al. 2010. Coding of facial expressions of pain in the laboratory mouse. Nat. Methods 7:447-449.
68. Le, M. K., H. J. Shin, G. Y. Yang, Y. W. Yoon, S. K. Han, Y. C. Bae, et al. 2010. Intracisternal and intraperitoneal administration of morphine attenuates mechanical allodynia following compression of the trigeminal ganglion in rats. J. Orofac. Pain 24:113-121.
69. Lewis, M. A., V. Sankar, A. De Laat, R. Benoliel. 2007. Management of neuropathic orofacial pain. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103(Suppl):S32.e1-S32.e24.
70. Lim, E. J., H. J. Jeon, G. Y. Yang, M. K. Lee, J. S. Ju, S. R. Han, et al. 2007. Intracisternal administration of mitogen-activated protein kinase inhibitors reduced mechanical allodynia following chronic constriction injury of infraorbital nerve in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 31:1322-1329.
71. Lipton, J. A., J. A. Ship, and D. Larach-Robinson 1993. Estimated prevalence and distribution of reported orofacial pain in the United States. J. Am. Dent. Assoc. 124:115-121.
72. List, T., A. Tegelberg, T. Haraldson, and G. Isacsson 2001. Intra-articular morphine as analgesic in temporomandibular joint arthralgia/osteoarthritis. Pain 94:275-282.
73. List, T., S. Axelsson, and G. Leijon 2003. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J. Orofac. Pain 17:301-310.
74. Luccarini, P., L. Perrier, C. Degoulange, A. M. Gaydier, and R. Dallel 2004. Synergistic antinociceptive effect of amitriptyline and morphine in the rat orofacial formalin test. Anesthesiology 100:690-696.
75. Luccarini, P., A. Childeric, A. M. Gaydier, D. Voisin, and R. Dallel 2006. The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. J. Pain 7:908-914.
76. Luiz, A. P., S. D. Schroeder, J. G. Chichorro, J. B. Calixto, A. R. Zampronio, and G. A. Rae 2010. Kinin B(1) and B(2) receptors contribute to orofacial heat hyperalgesia induced by infraorbital nerve constriction injury in mice and rats. Neuropeptides 44:87-92.
77. Macfarlane, T. V., A. S. Blinkhorn, R. M. Davies, P. Ryan, H. V. Worthington, and G. J. Macfarlane 2002. Orofacial pain: just another chronic pain? Results from a population-based survey. Pain 99:453-458.
78. Mantyh, P. W., D. R. Clohisy, M. Koltzenburg, and S. P. Hunt 2002. Molecular mechanisms of cancer pain. Nat. Rev. Cancer 2:201-209.
79. Marchand, F., M. Perretti, and S. B. McMahon 2005. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6:521-532.
80. Marquart, M. E. 2011. Animal models of bacterial keratitis. J. Biomed. Biotechnol. 2011:680642.
81. Martin, Y. B., and C. Avendano 2009. Effects of removal of dietary polyunsaturated fatty acids on plasma extravasation and mechanical allodynia in a trigeminal neuropathic pain model. Mol. Pain 5:8-17.
82. Martin, Y. B., E. Malmierca, C. Avendano, and A. Nunez 2010. Neuronal disinhibition in the trigeminal nucleus caudalis in a model of chronic neuropathic pain. Eur. J. Neurosci. 32:399-408.
83. McMahon, S. B., W. B. Cafferty, and F. Marchand 2005. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192:444-462.
84. McMahon, S. B., D. L. H. Bennett, and S. Bevan 2006. Inflammatory mediators and modulators of pain. Pp. 49-72 in S. B. McMahon and M. Koltzenburg, eds. Textbook of pain. Elsevier, London.
85. Mejersjö, C., and B. Wenneberg 2008. Diclofenac sodium and occlusal splint therapy in TMJ osteoarthritis: a randomized controlled trial. J. Oral Rehabil. 35:729-738.
86. Miranda, H. F., F. Sierralta, and J. C. Prieto 2009. Synergism between NSAIDs in the orofacial formalin test in mice. Pharmacol. Biochem. Behav. 92:314-318.
87. Mogil, J. S. 2009. Animal models of pain: progress and challenges. Nat. Rev. Neurosci. 10:283-294.
88. Moore, R. A., P. J. Wiffen, S. Derry, and H. J. McQuay 2011. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst. Rev. (3):CD007938.
89. Morgan, J. R., and G. F. Gebhart 2008. Characterization of a model of chronic orofacial hyperalgesia in the rat: contribution of NA(V) 1.8. J. Pain 9:522-531.
90. Mujakperuo, H. R., M. Watson, R. Morrison, and T. V. Macfarlane 2010. Pharmacological interventions for pain in patients with temporomandibular disorders. Cochrane Database Syst. Rev. CD004715.
91. Nagamine, K., N. Ozaki, M. Shinoda, H. Asai, H. Nishiguchi, K. Mitsudo, et al. 2006. Mechanical allodynia and thermal hyperalgesia induced by experimental squamous cell carcinoma of the lower gingiva in rats. J. Pain 7:659-670.
92. Navarro, A., M. T. Saldana, C. Perez, S. Torrades, and J. Rejas 2011. A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings. BMC Neurol. 11:7.
93. Neubert, J. K., N. T. Maidment, Y. Matsuka, D. W. Adelson, L. Kruger, and I. Spigelman 2000. Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo. Brain Res. 871:181-191.
94. Neubert, J. K., A. J. Mannes, J. Keller, M. Wexel, M. J. Iadarola, and R. M. Caudle 2005a. Peripheral targeting of the trigeminal ganglion via the infraorbital foramen as a therapeutic strategy. Brain Res. Brain Res. Protoc. 15:119-126.
95. Neubert, J. K., C. G. Widmer, W. Malphurs, H. L. Rossi, C. J. J. Vierck, and R. M. Caudle 2005b. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 116:386-395.
96. Neubert, J. K., C. King, W. Malphurs, F. Wong, J. P. Weaver, A. C. Jenkins, et al. 2008. Characterization of mouse orofacial pain and the effects of lesioning TRPV1-expressing neurons on operant behavior. Mol. Pain 4:43.
97. Niv, S., N. Manering, and D. C. Yeomans 2008. Trigeminal antinociception induced by intranasal carbon dioxide. IASP 12th World Congress on Pain Poster presentation PH 116.
98. Nolan, T. A., J. Hester, Y. Bokrand-Donatelli, R. M. Caudle, and J. K. Neubert 2011. Adaptation of a novel operant orofacial testing system to characterize both mechanical and thermal pain. Behav. Brain Res. 217:477-480.
99. Nomura, H., A. Ogawa, A. Tashiro, T. Morimoto, J. W. Hu, and K. Iwata 2002. Induction of Fos protein-like immunoreactivity in the trigeminal spinal nucleus caudalis and upper cervical cord following noxious and non-noxious mechanical stimulation of the whisker pad of the rat with an inferior alveolar nerve transection. Pain 95:225-238.
100. Obermann, M., M. S. Yoon, K. Sensen, M. Maschke, H. C. Diener, and Z. Katsarava 2008. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 28:174-181.
101. Ogawa, A., K. Ren, Y. Tsuboi, T. Morimoto, T. Sato, and K. Iwata 2003. A new model of experimental parotitis in rats and its implication for trigeminal nociception. Exp. Brain Res. 152:307-316.
102. Ono, K., N. Harano, S. Nagahata, Y. Seta, T. Tsujisawa, K. Inenaga, et al. 2009. Behavioral characteristics and c-Fos expression in the medullary dorsal horn in a rat model for orofacial cancer pain. Eur. J. Pain 13:373-379.
103. Padi, S. S., P. S. Naidu, and S. K. Kulkarni 2006. Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats. Inflammopharmacology 14:57-61.
104. Pelissier, T., J. Pajot, and R. Dallel 2002. The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine. Pain 96:81-87.
105. Poh, K. W., N. Lutfun, J. Manikandan, W. Y. Ong, and J. F. Yeo 2009. Global gene expression analysis in the mouse brainstem after hyperalgesia induced by facial carrageenan injection - evidence for a form of neurovascular coupling? Pain 142:133-141.
106. Quintans-Junior, L. J., M. S. Melo, D. P. De Sousa, A. A. Araujo, A. C. Onofre, D. P. Gelain, et al. 2010. Antinociceptive effects of citronellal in formalin-, capsaicin-, and glutamate-induced orofacial nociception in rodents and its action on nerve excitability. J. Orofac. Pain 24:305-312.
107. Raboisson, P., and R. Dallel 2004. The orofacial formalin test. Neurosci. Biobehav. Rev. 28:219-226.
108. Rappaport, Z. H., and M. Devor 1994. Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion. Pain 56:127-138.
109. Ren, K., and R. Dubner 1999. Inflammatory models of pain and hyperalgesia. ILAR J. 40:111-118.
110. Ro, J. Y. 2005. Bite force measurement in awake rats: a behavioral model for persistent orofacial muscle pain and hyperalgesia. J. Orofac. Pain 19:159-167.
111. Ro, J. Y., and N. F. Capra 2006. Assessing mechanical sensitivity of masseter muscle in lightly anesthetized rats: a model for craniofacial muscle hyperalgesia. Neurosci. Res. 56:119-123.
112. Rodrigues, L. L., M. C. Oliveira, A. Pelegrini-da-Silva, M. C. de Arruda, C. A. Parada, and C. H. Tambeli 2006. Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats. J. Pain 7:929-936.
113. Rosenfeld, J. P., J. G. Broton, and R. M. Clavier 1978. A reliable, facial nociception device for unrestrained, awake animals: effects of morphine and trigeminal complex lesions. Physiol. Behav. 21:287-290.
114. Rossi, C., A. Angelucci, L. Costantin, C. Braschi, M. Mazzantini, F. Babbini, et al. 2006. Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur. J. Neurosci. 24:1850-1856.
115. Roveroni, R. C., C. A. Parada, M. Cecilia, F. A. Veiga, and C. H. Tambeli 2001. Development of a behavioral model of TMJ pain in rats: the TMJ formalin test. Pain 94:185-191.
116. Seino, H., K. Seo, T. Maeda, and G. Someya 2009. Behavioural and histological observations of sensory impairment caused by tight ligation of the trigeminal nerve in mice. J. Neurosci. Methods 181:67-72.
117. Sessle, B. J. 2005. Peripheral and central mechanisms of orofacial pain and their clinical correlates. Minerva Anestesiol. 71:117-136.
118. Sessle, B. J. 2011. Peripheral and central mechanisms of orofacial inflammatory pain. Int. Rev. Neurobiol. 97:179-206.
119. Shinoda, M., M. Asano, D. Omagari, K. Honda, S. Hitomi, A. Katagiri, et al. 2011. Nerve growth factor contribution via transient receptor potential vanilloid 1 to ectopic orofacial pain. J. Neurosci. 31:7145-7155.
120. Sist, T. C., V. A. Filadora, M. Miner, and M. Lema 1997. Experience with gabapentin for neuropathic pain in the head and neck: report of ten cases. Reg. Anesth. 22:473-478.
121. Sluka, K. A., A. Kalra, and S. A. Moore 2001. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24:37-46.
122. Solaro, C., and U. M. Messmer 2010. Pharmacological management of pain in patients with multiple sclerosis. Drugs 70:1245-1254.
123. Solaro, C., G. L. Lunardi, E. Capello, M. Inglese, U. M. Messmer, A. Uccelli, et al. 1998. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology. 51:609-611.
124. Sotocinal, S. G., R. E. Sorge, A. Zaloum, A. H. Tuttle, L. J. Martin, J. S. Wieskopf, et al. 2011. The Rat Grimace Scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol. Pain 7:55.
125. Spaziante, R., P. Cappabianca, M. Saini, and E. de Divitiis 1995. Topical ophthalmic treatment for trigeminal neuralgia. J. Neurosurg. 82:699-700.
126. Stohler, C. S. 1999. Muscle-related temporomandibular disorders. J. Orofac. Pain 13:273-284.
127. Stoustrup, P., K. D. Kristensen, A. Kuseler, T. K. Pedersen, J. Gelineck, and T. Herlin 2009. Intra-articular vs. systemic administration of etanercept in antigen-induced arthritis in the temporomandibular joint. Part II: mandibular growth. Pediatr. Rheumatol. Online J. 7:6. doi: 10.1186/1546-0096-7-6
128. Swift, J. Q., M. T. Roszkowski, T. Alton, and K. M. Hargreaves 1998. Effect of intra-articular versus systemic anti-inflammatory drugs in a rabbit model of temporomandibular joint inflammation. J. Oral Maxillofac. Surg. 56:1288-1295.
129. Ta, L. E., and R. A. Dionne 2004. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen. Pain 111:13-21.
130. Takeda, M., S. Matsumoto, B. J. Sessle, M. Shinoda, and K. Iwata 2011. Peripheral and central mechanisms of trigeminal neuropathic and inflammatory pain. J. Oral Biosci. 53:318-329.
131. Tang, N., W. Y. Ong, J. F. Yeo, and A. A. Farooqui 2009. Anti-allodynic effect of intracerebroventricularly administered antioxidant and free radical scavenger in a mouse model of orofacial pain. J. Orofac. Pain 23:167-173.
132. Tarsa, L., E. Balkowiec-Iskra, F. J. Kratochvil III, V. K. Jenkins, A. McLean, A. L. Brown, et al. 2010. Tooth pulp inflammation increases brain-derived neurotrophic factor expression in rodent trigeminal ganglion neurons. Neuroscience 167:1205-1215.
133. Tashiro, A., K. Okamoto, Z. Chang, and D. A. Bereiter 2010. Behavioral and neurophysiological correlates of nociception in an animal model of photokeratitis. Neuroscience 169:455-462.
134. Thut, P. D., T. O. Hermanstyne, N. M. Flake, and M. S.Gold. 2007. An operant conditioning model to assess changes in feeding behavior associated with temporomandibular joint inflammation in the rat. J. Orofac. Pain 21:7-18.
135. Tzabazis, A., M. Klyukinov, N. Manering, M. I. Nemenov, S. L. Shafer, and D. C. Yeomans 2005. Differential activation of trigeminal C or A delta nociceptors by infrared diode laser in rats: behavioral evidence. Brain Res. 1037:148-156.
136. Vahidy, W. H., W. Y. Ong, A. A. Farooqui, and J. F Yeo 2006. Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. Exp. Brain Res. 174:781-785.
137. Vit, J. P., L. Jasmin, A. Bhargava, and P. T. Ohara 2006. Satellite glial cells in the trigeminal ganglion as a determinant of orofacial neuropathic pain. Neuron Glia Biol. 2:247-257.
138. Vit, J. P., P. T. Ohara, A. Bhargava, K. Kelley, and L. Jasmin 2008. Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury. J. Neurosci. 28:4161-4171.
139. Vos, B. P., A. M. Strassman, and R. J. Maciewicz 1994. Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J. Neurosci. 14:2708-2723.
140. Watson, C. P.. 2004. Management issues of neuropathic trigeminal pain from a medical perspective. J. Orofac. Pain 18:366-373.
141. Wiffen, P., S. Collins, H. McQuay, D. Carroll, A. Jadad, and A. Moore 2005. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst. Rev. CD001133.
142. Woda, A., S. Tubert-Jeannin, D. Bouhassira, N. Attal, B. Fleiter, J. P. Goulet, et al. 2005. Towards a new taxonomy of idiopathic orofacial pain. Pain 116:396-406.
143. Xu, M., M. Aita, and C. Chavkin 2008. Partial infraorbital nerve ligation as a model of trigeminal nerve injury in the mouse: behavioral, neural, and glial reactions. J. Pain 9:1036-1048.
144. Yang, G. Y., M. K. Lee, Y. C. Bae, and D. K. Ahn 2009. Intracisternal administration of COX inhibitors attenuates mechanical allodynia following compression of the trigeminal ganglion in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 33:589-595.
145. Yeo, J. F., W. Y. Ong, S. F. Ling, and A. A. Farooqui 2004. Intracerebroventricular injection of phospholipases A2 inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 112:148-155.
146. Yeo, J. F., S. F. Ling, N. Tang, and W. Y. Ong 2008. Antinociceptive effect of CNS peroxynitrite scavenger in a mouse model of orofacial pain. Exp. Brain Res. 184:435-438.
147. Zakrzewska, J. M. 2009. Facial pain: an update. Curr. Opin. Support Palliat. Care 3:125-130.
148. Zakrzewska, J. M. 2010. Facial pain. Pp. 134-150 in C. Stannard, E. Kalso, and J. Ballantyne, eds. Evidence-based chronic pain management. Blackwell Publishing, Oxford.
149. Zakrzewska, J. M., H. Forssell, and A. M. Glenny 2005. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst. Rev. CD002779.
150. Zhou, Q., H. Imbe, R. Dubner, and K. Ren 1999. Persistent Fos protein expression after orofacial deep or cutaneous tissue inflammation in rats: implications for persistent orofacial pain. J. Comp. Neurol. 412:276-291.